QUOTE AND NEWS
Market Intelligence Center  Jun 7  Comment 
Align Technology Inc (NASDAQ: ALGN) closed Thursday's trading session at $35.19. In the past year, the stock has hit a 52-week low of $23.45 and 52-week high of $39.82. Align Technology (ALGN) stock has been showing support around $34.40 and...
Benzinga  Jun 3  Comment 
Align Technology, Inc. (NASDAQ: ALGN) and Henry Schein Dental, the U.S. dental business of Henry Schein, Inc. (NASDAQ: HSIC), today announced the introduction of Realine(TM), an entry level, five-stage clear aligner product designed for very minor...
Market Intelligence Center  Jun 3  Comment 
Align Technology Inc (NASDAQ: ALGN) closed Friday's trading session at $35.75. In the past year, the stock has hit a 52-week low of $23.45 and 52-week high of $39.82. Align Technology (ALGN) stock has been showing support around $35.24 and...
Benzinga  May 28  Comment 
In a report published Tuesday, Jefferies analyst Brandon Couillard downgraded the rating on Align Technology (NASDAQ: ALGN) from Buy to Hold, but raised the price target from $36.00 to $38.00. In the report, Jefferies noted, “We are lowering...
Benzinga  May 28  Comment 
TheStreet.com  May 28  Comment 
NEW YORK (TheStreet) -- CHANGE IN RATINGS Align Technology was downgraded at Jefferies to hold from buy. Valuation call, based on a $38 price target, Jefferies said. Artisan Partners Asset Management was downgraded at Citigroup to...
Market Intelligence Center  May 21  Comment 
Align Technology Inc (NASDAQ: ALGN) closed Monday's trading session at $37.80. In the past year, the stock has hit a 52-week low of $23.45 and 52-week high of $39.82. Align Technology (ALGN) stock has been showing support around $37.07 and...
Benzinga  May 6  Comment 
Align Technology, Inc. (NASDAQ: ALGN) today announced that it has received notice that the International Trade Commission ("ITC") Administrative Law Judge (ALJ) has issued his Initial Determination finding that the ClearCorrect entities...
Market Intelligence Center  Apr 23  Comment 
Align Technology Inc (NASDAQ: ALGN) closed Monday's trading session at $32.00. In the past year, the stock has hit a 52-week low of $23.45 and 52-week high of $39.82. Align Technology (ALGN) stock has been showing support around $30.39 and...
StreetInsider.com  Apr 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Align+Technology%2C+Inc.+%28ALGN%29+Tops+Q1+EPS+by+4c%2C+Guides+Q2/8263498.html for the full story.
Market Intelligence Center  Apr 5  Comment 
Align Technology Inc (NASDAQ: ALGN) closed Thursday's trading session at $31.50. In the past year, the stock has hit a 52-week low of $23.45 and 52-week high of $39.82. Align Technology (ALGN) stock has been showing support around $30.09 and...




RELATED WIKI ARTICLES

Related Articles

 
TOP CONTRIBUTORS

Align Technology, Inc., founded in 1997, is engaged in the design, manufacture, and marketing of Invisalign, a proprietary system for treating malocclusion, or crooked teeth. The Invisalign product has two components, ClinCheck and Aligners. ClinCheck is an Internet-based application that allows dental professionals to simulate treatment in three dimensions, by modeling two-week stages of tooth movement. Aligners are thin, clear-plastic, removable dental appliances that are manufactured in a series to correspond to each two-week stage of the ClinCheck simulation. Aligners are customized to perform the treatment prescribed for an individual patient by dental professionals using ClinCheck. Invisalign is approved to treat patients, with any type of malocclusion, with mature upper and lower tooth structures. The company voluntarily restricts the use of Invisalign to adults and adolescents with immature structures. Typically, permanent structures occur in the later-teen years. Align does not treat children whose teeth and jaws are still developing, as the effectiveness of Invisalign relies on the company's ability to accurately predict the movement of teeth over the course of treatment. Based on its clinical studies to date, Align recommends that dental professionals use Invisalign as a complete treatment for a range of malocclusions, and as a component of treatment for severe malocclusions.


Internationally, the company operates in the regions of Europe, Asia/Pacific, and Latin America. At the end of 2007, sales in the domestic orthodontist channel represented 30% of total revenues, while sales in the domestic general practitioner (GP) channel represented 46%, and the international channel represented 20%. The remaining 5% came from education training and other revenues.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki